Revenue: As of FY2026 Q1, the actual value is USD 1.443 M.

EPS: As of FY2026 Q1, the actual value is USD -0.27.

EBIT: As of FY2026 Q1, the actual value is USD -26.31 M.

Overview and Outlook

Innventure, Inc. reported a strong start to 2026, driven by commercial momentum across its three operating companies, with management expressing confidence that 2026 will be an inflection year for the company. The company is seeing tangible commercial progress, improving financial discipline, and growing validation of its model, focused on building long-term value for shareholders.

Financial Performance (Three Months Ended March 31, 2026 vs. March 31, 2025)

Revenue

Revenue increased significantly to $1,443 thousand for Q1 2026, compared to $224 thousand for Q1 2025.

Operating Costs and Expenses

• Cost of sales rose to $5,253 thousand in Q1 2026 from $184 thousand in Q1 2025.
• General and administrative expenses declined by 35% year over year, reaching $12,750 thousand in Q1 2026, down from $19,676 thousand in Q1 2025, reflecting continued progress on cost discipline.
• Sales and marketing expenses were $2,897 thousand in Q1 2026, up from $2,096 thousand in Q1 2025.
• Research and development expenses increased to $7,840 thousand in Q1 2026 from $6,253 thousand in Q1 2025.
• Goodwill impairment was $0 in Q1 2026, a substantial improvement from $233,213 thousand in Q1 2025.
• Total operating expenses significantly decreased to $28,740 thousand in Q1 2026 from $261,422 thousand in Q1 2025.

Profitability

• Loss from operations improved to - $27,297 thousand in Q1 2026, compared to - $261,198 thousand in Q1 2025.
• Net loss was - $27,783 thousand for Q1 2026, a considerable reduction from - $253,674 thousand in Q1 2025.
• Net loss attributable to Innventure, Inc. stockholders was - $20,805 thousand in Q1 2026, down from - $142,997 thousand in Q1 2025.

Cash Flow (Three Months Ended March 31, 2026 vs. March 31, 2025)

• Net cash used in operating activities increased to - $34,031 thousand in Q1 2026 from - $14,696 thousand in Q1 2025.
• Net cash used in investing activities was - $846 thousand in Q1 2026, an improvement from - $3,254 thousand in Q1 2025.
• Net cash provided by financing activities was $29,795 thousand in Q1 2026, up from $8,206 thousand in Q1 2025.
• The net decrease in cash, cash equivalents, and restricted cash was - $5,082 thousand in Q1 2026, compared to - $9,744 thousand in Q1 2025.
• Cash, cash equivalents, and restricted cash at the end of the period were $60,367 thousand in Q1 2026, significantly higher than $1,375 thousand in Q1 2025.

Non-GAAP Financial Measures

• EBITDA was - $24,162 thousand in Q1 2026, an improvement from - $247,987 thousand in Q1 2025.
• Adjusted EBITDA was - $18,416 thousand in Q1 2026, compared to - $21,824 thousand in Q1 2025.